- Aarti Pharmalabs has inaugurated Phase 1 of its new greenfield manufacturing facility in Atali, Gujarat.
- The site adds 420 KL reactor capacity and becomes the company’s seventh manufacturing facility.
Aarti Pharmalabs has announced the inauguration of Phase 1 of its new greenfield manufacturing facility in Atali, Gujarat. The site becomes the company’s seventh manufacturing plant and is set to play a key role in expanding its CDMO services.
The first phase includes a total reactor capacity of 420 KL across 59 reactors. According to the company, the design of the facility meets global standards for pharmaceutical production.
The new greenfield site spans 80 acres and has been planned with scalability in mind. Capacity can be expanded up to eight to ten times its current size to meet future growth and demand.
Aarti Pharmalabs stated: “This state-of-the-art facility marks our seventh manufacturing site and will be a key growth engine for our CDMO services.”
